Relay Therapeutics (NASDAQ:RLAY) just reported results for the first quarter of 2024.
- Relay Therapeutics reported earnings per share of -62 cents. This was above the analyst estimate for EPS of -71 cents.
- The company reported revenue of $10.01 million.
- This was 11,018.89% better than the analyst estimate for revenue of $90,000.